Kirsty Bhattacharya

Suggest Changes
Learn More
Objective. To determine if therapy with an ergot and a non-ergot dopamine agonist and levodopa confers an increased risk of excessive daytime sleepiness and secondary "sleep attacks" in Parkinson's(More)
  • 1